Association between HIV infection and hypertension: a global systematic review and meta-analysis of cross-sectional studies

Autor: Pablo N Perez-Guzman, Kate Davis, Amy C. Justice, Edward W. Gregg, Annika Hoyer, Ralph Brinks, Keri N. Althoff, Simon Gregson, Mikaela Smit, Peter Reiss
Přispěvatelé: Global Health, Infectious diseases, AII - Infectious diseases, APH - Aging & Later Life, Wellcome Trust, Medical Research Council (MRC)
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Cross-sectional study
Human immunodeficiency virus (HIV)
BLOOD-PRESSURE
HIV Infections
030204 cardiovascular system & hematology
medicine.disease_cause
Global Health
0302 clinical medicine
ANTIRETROVIRAL THERAPY
Risk Factors
Global health
030212 general & internal medicine
SUB-SAHARAN AFRICA
11 Medical and Health Sciences
METABOLIC SYNDROME
CARDIOVASCULAR RISK
General Medicine
Middle Aged
PREVALENCE
3. Good health
Meta-analysis
Hypertension
Blood pressure
Medicine
Life Sciences & Biomedicine
Research Article
Adult
ACUTE MYOCARDIAL-INFARCTION
MEDLINE
03 medical and health sciences
Medicine
General & Internal

PEOPLE
General & Internal Medicine
medicine
Humans
Aged
Science & Technology
business.industry
Correction
HIV
IMMUNODEFICIENCY-VIRUS-INFECTION
Cross-Sectional Studies
Relative risk
RISK-FACTORS
Systematic review
Observational study
business
Demography
Zdroj: BMC Medicine, Vol 19, Iss 1, Pp 1-16 (2021)
BMC Medicine
BMC medicine, 19(1):105. BioMed Central
ISSN: 1741-7015
Popis: Background Improved access to effective antiretroviral therapy has meant that people living with HIV (PLHIV) are surviving to older ages. However, PLHIV may be ageing differently to HIV-negative individuals, with dissimilar burdens of non-communicable diseases, such as hypertension. While some observational studies have reported a higher risk of prevalent hypertension among PLHIV compared to HIV-negative individuals, others have found a reduced burden. To clarify the relationship between HIV and hypertension, we identified observational studies and pooled their results to assess whether there is a difference in hypertension risk by HIV status. Methods We performed a global systematic review and meta-analysis of published cross-sectional studies that examined hypertension risk by HIV status among adults aged > 15 (PROSPERO: CRD42019151359). We searched MEDLINE, EMBASE, Global Health and Cochrane CENTRAL to August 23, 2020, and checked reference lists of included articles. Our main outcome was the risk ratio for prevalent hypertension in PLHIV compared to HIV-negative individuals. Summary estimates were pooled with a random effects model and meta-regression explored whether any difference was associated with study-level factors. Results Of 21,527 identified studies, 59 were eligible (11,101,581 participants). Crude global hypertension risk was lower among PLHIV than HIV-negative individuals (risk ratio 0.90, 95% CI 0.85–0.96), although heterogeneity between studies was high (I2 = 97%, p Conclusions Our findings suggest that the relationship between HIV status and prevalent hypertension differs by region. The results highlight the need to tailor hypertension prevention and care to local contexts and underscore the importance of rapidly optimising integration of services for HIV and hypertension in the worst affected regions. The role of different risk factors for hypertension in driving context-specific trends remains unclear, so development of further cohorts of PLHIV and HIV-negative controls focused on this would also be valuable.
Databáze: OpenAIRE